Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

BACKGROUND AND OBJECTIVES: The effectiveness and tolerability of tapentadol extended release (ER), a centrally acting analgesic with μ-opioid receptor agonist and norepinephrine (noradrenaline) reuptake inhibitor activities, have been demonstrated in patients with chronic pain, including those switc...

Descripción completa

Detalles Bibliográficos
Autores principales: Imanaka, Keiichiro, Tominaga, Yushin, Etropolski, Mila, Ohashi, Hiroki, Hirose, Keiichiro, Matsumura, Taka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062813/
https://www.ncbi.nlm.nih.gov/pubmed/24906437
http://dx.doi.org/10.1007/s40261-014-0204-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062813/
https://www.ncbi.nlm.nih.gov/pubmed/24906437
http://dx.doi.org/10.1007/s40261-014-0204-3

Ejemplares similares